Overview

A Comparison of the Effectiveness of Seroquel XR and Seroquel XR Plus Lithium in Patients With Acute Bipolar Mania: An Open-label, Randomized, Parallel Groups, Rater-blinded, 4 Week, Multicenter, Comparative,Study

Status:
Terminated

Trial end date:
2012-10-01

Target enrollment:

Participant gender:

Summary

The primary objective of this study is to compare the efficacy of Seroquel XR monotherapy compared with Seroquel XR plus lithium in the treatment of acute bipolar mania by evaluation of the changes from baseline in Young Mania Ratings Scale (YMRS) total score to Day 29 using the last observation carried forward method.

Phase:

Phase 4

Details

Lead Sponsor:

AstraZeneca

Treatments:

Lithium Carbonate
Quetiapine Fumarate